Ordering Recommendation

May be helpful when assessing HAV immunity. Not generally recommended to diagnose acute infection. Assay detects both IgG and IgM antibodies but does not differentiate between them.

New York DOH Approval Status

This test is New York state approved.

Specimen Required

Patient Preparation
Collect

Serum separator tube.

Specimen Preparation

Separate serum from cells ASAP or within 2 hours of collection. Transfer 1 mL serum to an ARUP Standard Transport Tube. (Min: 0.5 mL) Also acceptable: K2EDTA plasma.

Storage/Transport Temperature

Refrigerated.

Unacceptable Conditions

Specimens collected in citrate-based anticoagulant. Specimens containing particulate material. Heat-inactivated, severely hemolyzed, or lipemic specimens.

Remarks
Stability

After separation from cells: Ambient: Unacceptable; Refrigerated: 1 week; Frozen: Indefinitely (avoid repeated freeze/thaw cycles)

Methodology

Qualitative Chemiluminescent Immunoassay

Performed

Sun-Sat

Reported

Within 24 hours

Reference Interval

Negative

Interpretive Data



Compliance Category

FDA

Note

This assay tests for IgG and IgM antibodies, but does not differentiate between them.

Hotline History

N/A

CPT Codes

86708

Components

Component Test Code* Component Chart Name LOINC
0020591 Hepatitis A Antibodies, Total 13951-9
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.

Aliases

  • HAV Ab Total
  • HAV immunity determination
  • HAV vaccination status
  • Hep A vaccination status
  • Hepatitis A Antibody
Hepatitis A Virus Antibodies (Total)